Roundup: Australian startup's COVID-19 diagnosis tool, Vocera inks distribution deal with Wavelink, and more briefs

Also, Genesis MedTech closes Series B funding round.
By Thiru Gunasegaran
04:29 am
Share

Credit: Rulestar

Australian legal tech startup creates COVID-19 diagnosis tool

Rulestar has used its automation platform to turn a static flowchart about COVID-19 diagnosis into an online tool.

The startup, whose platform is used to automate complex legal documents, said the new diagnosis tool will help exhausted medical workers in expediting decision-making and raising the quality of their decisions.

"We looked up what's involved in triaging a potential [c]oronavirus patient: the logic isn't simple. We figured that it's dangerous to expect exhausted and stressed-out frontline workers to follow something like that," Rulestar Managing Director David Lipworth said in a statement.

The company also announced it will open its platform globally for do-it-yourself automation across all industries.


US-based Vocera inks distribution deal with Australian tech distributor

Vocera Communications, a US-based provider of clinical communication and workflow solutions, has signed a deal with Australian technology distributor Wavelink.

Wavelink will be marketing Vocera's solutions, including hands-free communication devices, mobile apps and an enterprise-wide clinical workflow platform, to healthcare organisations across Australia.

Vocera leverages the interoperability of its platform with more than 150 clinical and operational systems, helping reduce alarm fatigue, hasten staff response times and enhance patient care, safety, and experience.

Wavelink also distributes a range of products from Alcatel-Lucent Enterprise, Fortinet, Spectralink, Olinqua and CenTrak.


Genesis MedTech completes Series B funding

Genesis MedTech has raised an undisclosed amount from a Series B financing round led by General Atlantic, a US-based equity firm managing around $53 billion assets. CITIC Capital also joined the investing bout.

In a statement, the medical device maker said it will use its fresh funds to research and develop new products, market existing products and expand its business across emerging markets.

"We will also invest in adding premier talent, consolidating our R&D capabilities, incubating new technologies, and continuing to pursue solutions that answer the real needs of patients and healthcare practitioners – delivering impact where it is needed most," Genesis Medtech Chairman and CEO Warren Wang said in a press statement.

Recently, the company introduced its latest laparoscopic instruments in China and Singapore following a distribution deal with LivsMed, a Korean medical device firm.


United Imaging launches new medical imaging platforms

Shanghai-based medical equipment maker United Imaging Healthcare has unveiled its latest medical imaging platforms.

Its newest uAIFI technology platform is capable of contactless vital signals remote sensing, smart high-fidelity image reconstruction and intelligent constellation shuttling imaging, among other features.

Additionally, its latest uExcel technology platform for PET/CT systems provides "significant performance enhancements, more powerful imaging capabilities, richer system functionalities, a better user experience and improved patient safety."

United Imaging wanted all its modalities to run on the same software system. "It is very important that all modalities of United Imaging share the same software system, just like all Apple's products use Apple's system," Al Zhang, chairman and CEO of United Imaging, said in a press statement.

"We are always in pursuit of innovation and new frontiers. Rather than innovating simply within each individual modality, we take the strategy of innovating across modalities to address increasingly demanding requirements for imaging and the patient experience," Zhang stated.

Share